DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Roseville, CA

9 verified pulmonary disease doctors in Roseville.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Brent Vanhoozen, MD

Pulmonary Disease

20 yrs NPPES
NPI 1093757445
5 MEDICAL PLAZA DR, SUITE 190, Roseville, CA 95661(916) 786-7498
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,311 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,311

Total received

63

Transactions

18

Paying companies

Top paying companies

AbbVie Inc.$277.38
ViiV Healthcare Company$209.23
GlaxoSmithKline, LLC.$171.53
Boehringer Ingelheim Pharmaceuticals, Inc.$108.33
Astellas Pharma US Inc$94.79
AstraZeneca Pharmaceuticals LP$74.20

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Brent Vanhoozen do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Alan Cubre, MD

Pulmonary Disease

20 yrs NPPES
NPI 1831131895
5 MEDICAL PLAZA DR, SUITE 190, Roseville, CA 95661(916) 786-7498
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. W Martin, MD

Pulmonary Disease

20 yrs NPPES
NPI 1174566566
5 MEDICAL PLAZA DR, SUITE 190, Roseville, CA 95661(916) 786-7498
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $4,838 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$4,838

Total received

198

Transactions

31

Paying companies

Top paying companies

Gilead Sciences, Inc.$1,093
ViiV Healthcare Company$753.69
Boehringer Ingelheim Pharmaceuticals, Inc.$449.04
AstraZeneca Pharmaceuticals LP$326.13
GlaxoSmithKline, LLC.$310.65
AbbVie Inc.$279.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to W Martin do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Imran Mohammed, MD

Pulmonary Disease

20 yrs NPPES
NPI 1174625396
5 MEDICAL PLAZA DR STE 190, Roseville, CA 95661(916) 679-3590
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,172 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,172

Total received

52

Transactions

15

Paying companies

Top paying companies

AbbVie Inc.$430.89
ViiV Healthcare Company$214.88
Boehringer Ingelheim Pharmaceuticals, Inc.$158.31
GlaxoSmithKline, LLC.$62.69
AstraZeneca Pharmaceuticals LP$60.57
Takeda Pharmaceuticals U.S.A., Inc.$38.17

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Imran Mohammed do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Lawrence Bistrong, MD

Pulmonary Disease

19 yrs NPPES
NPI 1275752677
5 MEDICAL PLAZA DR STE 190, Roseville, CA 95661(916) 679-3590
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,468 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,468

Total received

50

Transactions

14

Paying companies

Top paying companies

Medtronic, Inc.$708.28
ViiV Healthcare Company$214.33
Boehringer Ingelheim Pharmaceuticals, Inc.$152.34
Merck Sharp & Dohme LLC$68.43
AstraZeneca Pharmaceuticals LP$64.51
GlaxoSmithKline, LLC.$52.85

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Lawrence Bistrong do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Deepak Chandra, MD

Pulmonary Disease

14 yrs NPPES
NPI 1790030286
5 MEDICAL PLAZA DR STE 190, Roseville, CA 95661(916) 679-3590
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $644.04 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$644.04

Total received

30

Transactions

11

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$259.97
Grifols USA, LLC$68.06
Mylan Specialty L.P.$61.13
Baxter Healthcare$45.04
GlaxoSmithKline, LLC.$41.04
AstraZeneca Pharmaceuticals LP$33.16

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Deepak Chandra do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Noah Cook, MD

Pulmonary Disease

13 yrs NPPES
NPI 1093057564
5 MEDICAL PLAZA DR STE 190, Roseville, CA 95661(916) 786-7498
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $328.98 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$328.98

Total received

18

Transactions

6

Paying companies

Top paying companies

ViiV Healthcare Company$214.30
AbbVie Inc.$43.54
Amgen Inc.$20.51
Merck Sharp & Dohme LLC$20.48
Baxter Healthcare$15.73
EMD Serono, Inc.$14.42

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Noah Cook do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Elie Jean, MD

Pulmonary Disease

10 yrs NPPES
NPI 1558712182
5 MEDICAL PLAZA DR STE 190, Roseville, CA 95661(916) 679-3590
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $47.58 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$47.58

Total received

2

Transactions

2

Paying companies

Top paying companies

ViiV Healthcare Company$27.68
AstraZeneca Pharmaceuticals LP$19.90

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 53th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Elie Jean do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Andrew Kelada, MD

Pulmonary Disease

9 yrs NPPES
NPI 1417488123
680 SUNRISE AVE, Roseville, CA 95661(916) 786-4700
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $401.74 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$401.74

Total received

4

Transactions

3

Paying companies

Top paying companies

Inari Medical, Inc.$151.76
Amgen Inc.$125.00
Shionogi Inc$124.98

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 71th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Andrew Kelada do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Roseville, CA — Verified | DoctorsProof | DoctorsProof